Searchable abstracts of presentations at key conferences in endocrinology

ea0090p62 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Utility of using Continuous Glucose Monitoring based MetaSense in OneCare Diabetes care program in driving the metabolic outcomes in People with Diabetes Mellitus – A real world data from urban India

G S Basavaraj , Fatema Zareen , DM Mahesh , Dasyam Srinivas , BS Narendra

Background: As adoption of continuous glucose monitoring (CGM) continues to expand, lot more studies are investigating the effects of CGM on HbA1C and hypoglycaemia risks in people with Diabetes Mellitus (PwD). In PwD, established benefits of usage of CGM along with digital diabetes self-management and education (DSME) program in Indian real-world context are scarce. OneCare compares patients engaged in its “IMPACT’ DSME program alone vs program assisted by CGM.<...

ea0090ep310 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effectiveness of OneCare digital diabetes IMPACT care program in patients with type 2 diabetes mellitus: An open label randomized controlled trial protocol

Fatema Zareen , Rajesh Shalini , Thakur Preyander Singh , Kamath Deepa , G S Basavaraj

Background: People with Diabetes (PwD) experience many obstacles in diabetes management including, but not limited to lack of motivation, limited knowledge on diabetes self-management and treatment adherence issues. Diabetes mandates regular follow-ups for good glycemic control and manage complications. Internet and smartphones, have revolutionized digital health and hence by employing digital health and technology, better outcomes may be achieved; which is realizable in India...

ea0026p221 | Pituitary | ECE2011

PANCH tumor in a female patient

Tsentidis C T , Antoniou-Tsigos A A , Dimarakis V D , Georgakopoulou G S , Prokovas P I , Argyropoulos A A

Case report: We present the case of a patient with somatotroph adenoma combined with neuronal choristoma Pituitary Adenoma Neuronal CHoristoma (PANCH). A female patient, 44 years of age, manifested with acromegaly type features since 1993, while mentioning also headaches, amenorrhea, and peripheral type visual disturbances since 1997. The clinical examination revealed an obese woman with typical acromegalic features. The laboratory evaluation before pituitary surgery showed a ...

ea0086p133 | Thyroid | SFEBES2022

Comparison of supervised rapid thyroxine absorption test in refractory and well-controlled primary hypothyroid patients in a tertiary care center in Sri Lanka and formulation of a prediction model to predict the expected FT4 rise during the test

G K Amiyangoda C , Antonypillai C N , Gunatilake S S C G , Ediriweera D , Kosgollana S G P D , Jayawardena R D P , Thissera H A N D , Emalka W J , Deraniyagala H U

Introduction: Refractory hypothyroidism is associated with significantly increased morbidity and healthcare costs. During the evaluation of refractory disease, a thyroxine absorption test is frequently performed using different protocols. We assessed the usefulness of the supervised rapid thyroxine absorption test in a low-resource setting and formulated a useful model to determine the expected FT4 rise in hypothyroid patients without known malabsorption.<p class="abstext"...

ea0090p140 | Pituitary and Neuroendocrinology | ECE2023

Molecular and clinical relevance of the somatostatin system in brain tumors

De la Rosa-Herencia Ana S. , G-Garcia Miguel E. , Vazquez-Borrego Mari C. , Blanco Acevedo Cristobal , Solivera Juan , Gahete Manuel D. , Fuentes-Fayos Antonio C. , M Luque Raul

High-grade astrocytomas (HGAs) remain the most prevalent and malignant brain tumor based on its locally aggressive behavior, being glioblastoma (grade-IV astrocytoma) the most lethal. The current standard treatment for glioblastomas consists of surgery followed by radiotherapy and/or chemotherapy. However, the average period of survival is about 14 months after the first intervention. Therefore, there is a clear clinical need for the identification of novel diagnostic, prognos...

ea0021cm3.3 | Management of congenital adrenal hyperplasia across the lifespan | SFEBES2009

The adult with CAH: results of the UK congenital adrenal hyperplasia, adult study executive (CaHASE)

Ross R J , Willis D S , Wild S H , Krone N , Doherty E J , Han T S , Carroll P V , Conway G S , Rees D A , Stimson R H , Walker B R , Connell J C , Arlt W

Background: No treatment guidelines exist for CAH adults. To address this we have undertaken a cross-sectional analysis of health status.Patients and methods: Three hundred and eighty patients from 17 tertiary centres were contacted: 203 (53%) consented (138 f, 65 m, median age 34 (range 18–69) years). One hundred and sixty-five had classic and 34 non-classic CAH. The UK prevalence is 3591 adults >18 years therefore the capture rate was 5.7%. Re...

ea0073aep381 | Endocrine-Related Cancer | ECE2021

Case report: Secondary adrenal insufficiency and primary hypothyroidism following Nivolumab therapy in a patient with metastatic melanoma

Paloma González Lázaro , Tirado Antonio Moreno , Pascual Cristina Contreras , Mendez Cristina Montalban , María Zhao Montero Benítez , Inés Gómez García

IntroductionIn recent years, we have observed significant progress in cancer treatment associated with the development of immunotherapy. Nivolumab, an anti-PD-1 antibody, blocks the interaction between PD-1 and its ligands and inhibits the signaling pathway by preventing the tumor-derived PD-L1 from blocking T lymphocytes. In patients with metastatic melanoma, it is used either in monotherapy or in combination with other drugs. Immunotherapy is associate...

ea0041ep195 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Liposomal prednisolone promotes macrophage necroptosis in experimental atherosclerosis: does this explain atherogenesis in Cushing’s disease?

Schulte Dominik M , van der Valk Fleur M , Meiler Svenja , Tang Jun , Zheng Kang He , van den Bossche Jan , Seijkens Tom , Laudes Matthias , de Winther Menno , Lutgens Esther , Alaarg Amr , Metselaar Josbert M , Dallinga-Thie Geesje M , Mulder Willem J M , Stroes Erik S G , Hamers Anouk A J

Introduction: Patients with a Cushing syndrome – a glucocorticoid driven disease–have a high risk for cardiovascular events, mainly due to atherosclerosis. Atherosclerosis is a lipid-driven inflammatory disease, for which novel anti-inflammatory strategies like glucocorticoids are under evaluation. Thus, the impact of glucocorticoids on atherosclerosis seems to be ambiguous: pro- or anti-inflammatory. To avoid systemic glucocorticoid side effects contributing to athe...

ea0073aep454 | General Endocrinology | ECE2021

Acute pancreatitis in a covid-19 patient

Maria Zhao Montero Benítez , Pascual Cristina Contreras , Mendez Cristina Montalban , Tirado Antonio Moreno , Paloma González Lázaro , Florentino Del Val Zaballos , Julia Silva-Fernández , Meneses Amparo Lomas , Francisco Javier Gómez Alfonso , Inés Gómez García

Acute pancreatitis (AP) is an inflammatory disorder of the pancreas, most commonly caused by gallstones and heavy alcohol consumption. The diagnosis is established with at least 2 of the following criteria: abdominal pain; increased serum lipase/amylase levels greater than 3 times the upper limit of normal value; or characteristic findings on contrast computed tomography (CT). Since the beginning of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic, a few...

ea0073ep202 | Thyroid | ECE2021

Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.

Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Maria Zhao Montero Benítez , Paloma González Lázaro , Julia Silva-Fernández , Florentino Del Val Zaballos , Francisco Javier Gómez Alfonso , Lomas Meneses Amparo , Inés Gómez García

Selpercatinib is a receptor tyrosine kinase RET inhibitor for the treatment of cancers such as RET-mutant medullary thyroid cancer, demonstrating partial response and low incidence of serious adverse events. Vandetanib, a tyrosine kinase inhibitor, has shown promising results with an increase in progression-free survival and prolonged lifetime, but it causes adverse events such as hypertension, diarrhea, rash, or long QT interval. Most of them are can be even disabling for the...